VanEck Biotech ETF
BBH
NASDAQ
| Weiss Ratings | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Valuation | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Price | $162.56 | |||
| Company Info | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | VanEck | |||
| Manager/Tenure (Years) | Peter H. Liao (13), Griffin Driscoll (1) | |||
| Website | http://www.vaneck.com | |||
| Phone Number | 800-826-1115 | |||
| Fund Information | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | VanEck Biotech ETF | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Unaligned | |||
| Inception Date | Dec 20, 2011 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | -- | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.82% | |||
| Dividend | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 1.02% | |||
| Asset Allocation | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.07% | |||
| Stock | 99.93% | |||
| U.S. Stock | 99.93% | |||
| Non-U.S. Stock | 0.00% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -2.51% | |||
| 30-Day Total Return | 3.58% | |||
| 60-Day Total Return | 8.39% | |||
| 90-Day Total Return | 6.12% | |||
| Year to Date Total Return | 2.58% | |||
| 1-Year Total Return | -10.41% | |||
| 2-Year Total Return | 2.37% | |||
| 3-Year Total Return | 7.18% | |||
| 5-Year Total Return | -0.19% | |||
| Price | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | $163.77 | |||
| 1-Month Low Price | $154.79 | |||
| 1-Month High Price | $165.12 | |||
| 52-Week Low Price | $140.05 | |||
| 52-Week Low Price (Date) | May 09, 2025 | |||
| 52-Week High Price | $182.72 | |||
| 52-Week High Price (Date) | Aug 21, 2024 | |||
| NAV | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 1-Month Low NAV | $154.85 | |||
| 1-Month High NAV | $165.14 | |||
| 52-Week Low NAV | $139.93 | |||
| 52-Week Low NAV (Date) | May 09, 2025 | |||
| 52-Week High NAV | $182.64 | |||
| 52-Week High Price (Date) | Aug 21, 2024 | |||
| Beta / Standard Deviation | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.00 | |||
| Standard Deviation | 16.91 | |||
| Balance Sheet | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 330.62M | |||
| Operating Ratios | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.35% | |||
| Turnover Ratio | 19.00% | |||
| Performance | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 7.10% | |||
| Last Bear Market Total Return | -10.06% | |||